Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1188, pseudogene (RNU6-1188P) is a processed pseudogene corresponding to the U6 small nuclear RNA (snRNA) family[1][2]. U6 snRNAs are integral non-coding RNAs of the spliceosomal machinery and play a crucial role in pre-mRNA splicing by forming the catalytic core of the spliceosome[3][5]. However, as a pseudogene, RNU6-1188P does not produce a functional RNA product and lacks established biological, pathological, or therapeutic significance in current biomedical literature[1][2][7]. Pseudogenes like RNU6-1188P arise via retrotransposition or genomic duplication and are typically non-functional relics dispersed through the genome, sometimes used in evolutionary studies as markers of genomic rearrangement[7]. There is no evidence that RNU6-1188P itself acts as a therapeutic target, nor are there any drugs, known disease roles, or biomarker/utilization in clinical medicine associated with this specific pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1188, pseudogene (RNU6-1188P).